Implanet receives FDA clearance for JAZZ braid: 5 key points

Implanet received FDA clearance from U.S. and European regulatory authorities to market its updated JAZZ braid.

Advertisement

Here are five key points:

 

1. This redesigned JAZZ braid comes in response to surgeon feedback since the original launch in 2013.

 

2. Technical characteristics have been improved, with part of the band now ultrasonically bonded. The braid will also continue to interface with the proprietary JAZZ tensioning system.

 

3. The new braid focuses on technological improvements to simply surgical procedures and facilitates the use of JAZZ in new surgical indications.

 

4. This is the 10th Implanet JAZZ product to receive FDA approval.

 

5. Implanet is a medical technology company specializing in vertebral and knee surgery implants.

 

More articles on devices and implants:
Zyga Technologies receives patent for SImmetry Decorticator: 5 things to know
Stryker gives $375 surgical equipment donation to Mayfield Education & Research Foundation: 5 highlights
SpineGuard, XinRong Medical Group sign distribution agreement for PediGuard: 5 insights

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.